Sporadic Creutzfeldt–Jakob Disease Appears to Be Sporadic Fatal Insomnia: A Case Report and Review of the Literature

Abstract Creutzfeldt–Jakob disease (CJD) subtypes are difficult to identify due to the heterogeneity of the clinical phenotype, and early accurate identification of sporadic CJD (sCJD) subtypes aids prognosis prediction. Currently, the diagnosis of sCJD subtypes is mainly based on brain tissue biopsy or autopsy. In this report, we present a case of confirmed sCJD initially presenting as insomnia. We described detailed information including clinical, electroencephalographic, polysomnographic, positron emission tomography-computed tomographic and other neuroimaging findings, cerebrospinal fluid biomarkers, skin tissue biopsy and whole blood PRNP gene sequencing in this patient. An extensive literature search was performed in order to better understand the diagnosis of various sCJD subtypes, particularly the thalamic form, sCJDMM2 (also known as sporadic fatal insomnia). Our study highlights sporadic fatal insomnia as a differential diagnosis of sCJD.

[1]  B. Caughey,et al.  Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease , 2021, The Lancet Neurology.

[2]  Yue Lang,et al.  Clinical manifestations and polysomnography-based analysis in nine cases of probable sporadic Creutzfeldt-Jakob disease , 2021, Neurological Sciences.

[3]  A. Bizzi,et al.  Subtype Diagnosis of Sporadic Creutzfeldt–Jakob Disease with Diffusion Magnetic Resonance Imaging , 2020, Annals of neurology.

[4]  H. Mizusawa,et al.  MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[5]  W. Surewicz,et al.  A novel mechanism of phenotypic heterogeneity in Creutzfeldt-Jakob disease , 2020, Acta Neuropathologica Communications.

[6]  A. Green,et al.  Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC , 2019, Journal of Neurology.

[7]  S. Sorbi,et al.  Sporadic Fatal Insomnia in Europe: Phenotypic Features and Diagnostic Challenges , 2018, Annals of neurology.

[8]  I. Zerr,et al.  Sporadic Creutzfeldt-Jakob disease. , 2011 .

[9]  P. Gambetti,et al.  Fatal familial insomnia and sporadic fatal insomnia. , 2018, Handbook of clinical neurology.

[10]  Y. Iwasaki.  Creutzfeldt‐Jakob disease , 2017, Neuropathology : official journal of the Japanese Society of Neuropathology.

[11]  M. Geschwind.  Prion Diseases , 2015, Continuum.

[12]  J. Langeveld,et al.  MM2‐Thalamic Creutzfeldt–Jakob Disease: Neuropathological, Biochemical and Transmission Studies Identify a Distinctive Prion Strain , 2012, Brain pathology.

[13]  A. Bizzi,et al.  Sporadic human prion diseases: molecular insights and diagnosis , 2012, The Lancet Neurology.

[14]  T. Sato,et al.  Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease , 2005, Neurology.

[15]  B. Mollenhauer,et al.  Sporadic Creutzfeldt-Jakob disease , 2004, Neurology.

[16]  E. Beck,et al.  Creutzfeldt-Jakob disease , 1973, Zeitschrift für Neurologie.

[17]  Pierluigi Gambetti,et al.  Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia. , 2003, Clinics in laboratory medicine.

[18]  J. Wiltfang,et al.  Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease , 2002, Neurology.

[19]  M. Haltia,et al.  Human prion diseases , 2000, Annals of medicine.

[20]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[21]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[22]  S. Prusiner,et al.  Human prion diseases , 1994, Annals of neurology.

[23]  C. Sigurdson,et al.  [Prion diseases?]. , 1985, Deutsche medizinische Wochenschrift.